BenevolentAI

BenevolentAI integrates knowledge graphs with generative models to surface novel drug candidates and runs internal programs. Relative to Numerion Labs, it covers a wider range of disease areas beyond immune indications and relies more on curated biomedical data. Access is typically granted through strategic partnerships.